Calibration of multisite raters for prospective visual reads of amyloid PET scans.
(2025 Oct)
Alzheimers Dement 21(10): e70732
Soleimani-Meigooni DN, Pezzoli S, Blazhenets G, La Joie R, Lin Z, Soppe CL, Johnson DR, Koran MEI, McConathy JE, Nasrallah IM, Ponisio MR, Tanner JA, Villemagne VL, Windon CC, Zeineh M, Biber S, Kukull WA, O'Connell H, Peterson DJ, Mormino EC, Johnson SC, Rabinovici GD, LEADS Consortium, PREVENT‐AD Research Group, Alzheimer's Disease Neuroimaging Initiative

Neuropsychiatric symptom subtypes and dementia-associated neuropathologic change.
(2025 Sep)
Alzheimers Dement 21(9): e70622
Cholerton BA, Beecham GW, Reitz C, De Vito AN, Cuccaro M, Kukull WA, Montine TJ, Huey ED

NACC data: Who is represented over time and across centers, and implications for generalizability.
(2025 Sep)
Alzheimers Dement 21(9): e70657
Chan KCG, Xia F, Kukull WA

Genome-wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures.
(2025 Sep)
Alzheimers Dement 21(9): e70681
Kang M, Ang TFA, Devine SA, Sherva R, Mukherjee S, Trittschuh EH, Scollard P, Lee M, Choi SE, Klinedinst B, Nakano C, Dumitrescu LC, Hohman TJ, Cuccaro ML, Saykin AJ, Kukull WA, Bennett DA, Wang LS, Mayeux RP, Haines JL, Pericak-Vance MA, Schellenberg GD, Crane PK, Au R, Lunetta KL, Mez J, Farrer LA

Amygdala-predominant Lewy bodies associate with cognitive decline and amygdala atrophy in Alzheimer's disease neuropathological change.
(2025 Sep 12)
J Neurol 272(9): 629
Almeida FC, Santos A, Jesus T, Gauthreaux K, Mock CN, Kukull WA, Crary JF, Oliveira TG